{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:35:53Z","timestamp":1791894953573,"version":"4.3.4"},"reference-count":137,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"DOI":"10.1186\/s12985-025-03020-1","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T16:26:05Z","timestamp":1764174365000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The virology of Omicron: pathophysiology, immune regulation, and clinical impact of SARS-CoV-2 sub variants"],"prefix":"10.1186","volume":"22","author":[{"given":"Nistha","family":"Mishra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya","family":"Goel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisarg","family":"Gangani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heerak","family":"Chugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavesh","family":"Kevadiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Tiwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Snigdha","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jai Gopal","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramesh","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,26]]},"reference":[{"key":"3020_CR1","unstructured":"Covid-19 cases in India [Internet]. Ministry of Health and Family Welfare, Goverment of India. https:\/\/www.mohfw.gov.in\/"},{"issue":"1","key":"3020_CR2","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1515\/med-2021-0266","volume":"16","author":"RK Mohapatra","year":"2021","unstructured":"Mohapatra RK, Mishra S, Azam M, Dhama K. COVID-19, WHO guidelines, pedagogy, and respite. Open Med. 2021;16(1):491\u20133. https:\/\/doi.org\/10.1515\/med-2021-0266.","journal-title":"Open Med"},{"issue":"7","key":"3020_CR3","doi-asserted-by":"publisher","first-page":"2986","DOI":"10.1002\/jmv.27717","volume":"94","author":"VP Chavda","year":"2022","unstructured":"Chavda VP, Patel AB, Vaghasiya DD. SARS\u2010CoV\u20102 variants and vulnerability at the global level. J Med Virol. 2022;94(7):2986\u20133005. https:\/\/doi.org\/10.1002\/jmv.27717.","journal-title":"J Med Virol"},{"key":"3020_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2022.106861","volume":"105","author":"N Shaheen","year":"2022","unstructured":"Shaheen N, Mohamed A, Soliman Y, Abdelwahab OA, Diab RA, Desouki MT, et al. Could the new BA.2.75 sub-variant lead to another COVID-19 wave in the world? \u2013 Correspondence. Int J Surg. 2022;105:106861. https:\/\/doi.org\/10.1016\/j.ijsu.2022.106861.","journal-title":"Int J Surg"},{"issue":"4","key":"3020_CR5","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1002\/jmv.27516","volume":"94","author":"L Wang","year":"2022","unstructured":"Wang L, Cheng G. Sequence analysis of the emerging SARS-CoV\u20102 variant Omicron in South Africa. J Med Virol. 2022;94(4):1728\u201333. https:\/\/doi.org\/10.1002\/jmv.27516.","journal-title":"J Med Virol"},{"key":"3020_CR6","doi-asserted-by":"publisher","unstructured":"Saito A, Tamura T, Zahradnik J, Deguchi S, Tabata K, Kimura I, Ito J, Nasser H, Toyoda M, Nagata K, Uriu K, Kosugi Y, Fujita S, Yamasoba D, Shofa M, Begum MM, Oda Y, Suzuki R, Ito H, Nao N, Wang L, Tsuda M, Yoshimatsu K, Yamamoto Y, Nagamoto T, Asakura H, Nagashima M, Sadamasu K, Yoshimura K, Ueno T, Schreiber G, Takaori-Kondo A; The Genotype to Phenotype Japan (G2P-Japan) Consortium;, Shirakawa K, Sawa H, Irie T, Takayama K, Matsuno K, Tanaka S, Ikeda T, Fukuhara T, Sato K. Virological Characteristics of the SARS-CoV-2 Omicron BA.2.75. August 8, 2022. https:\/\/doi.org\/10.1101\/2022.08.07.503115","DOI":"10.1101\/2022.08.07.503115"},{"issue":"5","key":"3020_CR7","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1002\/jmv.27541","volume":"94","author":"V Thakur","year":"2022","unstructured":"Thakur V, Ratho RK. OMICRON (B.1.1.529): a new SARS-CoV\u20102 variant of concern mounting worldwide fear. J Med Virol. 2022;94(5):1821\u20134. https:\/\/doi.org\/10.1002\/jmv.27541.","journal-title":"J Med Virol"},{"key":"3020_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2025.106092","volume":"235","author":"Q Wu","year":"2025","unstructured":"Wu Q, Wu H, Hu Y, Zheng X, Chang F, Liu Y, et al. Immune evasion of Omicron variants JN.1, KP.2, and KP.3 to the polyclonal and monoclonal antibodies from COVID-19 convalescents and vaccine recipients. Antiviral Res. 2025;235:106092. https:\/\/doi.org\/10.1016\/j.antiviral.2025.106092.","journal-title":"Antiviral Res"},{"key":"3020_CR9","doi-asserted-by":"publisher","unstructured":"Li P, Faraone JN, Hsu CC, Chamblee M, Zheng Y-M, Carlin C, Bednash JS, Horowitz JC, Mallampalli RK, Saif LJ, Oltz EM, Jones D, Li J, Gumina RJ, Xu K, Liu S-L. Characteristics of JN.1-Derived SARS-CoV-2 Subvariants SLip, FLiRT, and KP.2 in Neutralization Escape, Infectivity and Membrane Fusion. BioRxiv Prepr. Serv. Biol. 2024, 2024.05.20.595020. https:\/\/doi.org\/10.1101\/2024.05.20.595020","DOI":"10.1101\/2024.05.20.595020"},{"issue":"1","key":"3020_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-025-11040-z","volume":"25","author":"F Wang","year":"2025","unstructured":"Wang F, Zhu L, Chen Y, Li L. Clinical manifestations of SARS-CoV-2 Omicron infection is associated with the stage of liver cirrhosis. BMC Infect Dis. 2025;25(1):630. https:\/\/doi.org\/10.1186\/s12879-025-11040-z.","journal-title":"BMC Infect Dis"},{"key":"3020_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.bios.2020.112578","volume":"169","author":"R Funari","year":"2020","unstructured":"Funari R, Chu K-Y, Shen AQ. Detection of antibodies against SARS-CoV-2 spike protein by gold nanospikes in an opto-microfluidic chip. Biosens Bioelectron. 2020;169:112578. https:\/\/doi.org\/10.1016\/j.bios.2020.112578.","journal-title":"Biosens Bioelectron"},{"key":"3020_CR12","doi-asserted-by":"publisher","unstructured":"Willett BJ, Grove J, MacLean OA, Wilkie C, Logan N, Lorenzo GD, Furnon W, Scott S, Manali M, Szemiel A, Ashraf S, Vink E, Harvey WT, Davis C, Orton R, Hughes J, Holland P, Silva V, Pascall D, Puxty K, Da Silva Filipe A, Yebra G, Shaaban S, Holden MTG, Pinto RM, Gunson R, Templeton K, Murcia PR, Patel AH; The COVID-19 Genomics UK (COG-UK) Consortium;, Haughney J, Robertson DL, Palmarini M, Ray S, Thomson EC. The Hyper-Transmissible SARS-CoV-2 Omicron Variant Exhibits Significant Antigenic Change, Vaccine Escape and a Switch in Cell Entry Mechanism. January 3, 2022. https:\/\/doi.org\/10.1101\/2022.01.03.21268111","DOI":"10.1101\/2022.01.03.21268111"},{"issue":"6","key":"3020_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2021.167280","volume":"434","author":"MM Rajah","year":"2022","unstructured":"Rajah MM, Bernier A, Buchrieser J, Schwartz O. The mechanism and consequences of SARS-CoV-2 spike-mediated fusion and syncytia formation. J Mol Biol. 2022;434(6):167280. https:\/\/doi.org\/10.1016\/j.jmb.2021.167280.","journal-title":"J Mol Biol"},{"key":"3020_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.725528","volume":"8","author":"Y Rahbar Saadat","year":"2021","unstructured":"Rahbar Saadat Y, Hosseiniyan Khatibi SM, Zununi Vahed S, Ardalan M. Host serine proteases: a potential targeted therapy for COVID-19 and influenza. Front Mol Biosci. 2021;8:725528. https:\/\/doi.org\/10.3389\/fmolb.2021.725528.","journal-title":"Front Mol Biosci"},{"issue":"1","key":"3020_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-00997-x","volume":"7","author":"Y Fan","year":"2022","unstructured":"Fan Y, Li X, Zhang L, Wan S, Zhang L, Zhou F. SARS-CoV-2 Omicron variant: recent progress and future perspectives. Signal Transduct Target Ther. 2022;7(1):141. https:\/\/doi.org\/10.1038\/s41392-022-00997-x.","journal-title":"Signal Transduct Target Ther"},{"issue":"10","key":"3020_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.105044","volume":"25","author":"Q Chen","year":"2022","unstructured":"Chen Q, Zhang J, Wang P, Zhang Z. The mechanisms of immune response and evasion by the main SARS-CoV-2 variants. iScience. 2022;25(10):105044. https:\/\/doi.org\/10.1016\/j.isci.2022.105044.","journal-title":"iScience"},{"key":"3020_CR17","doi-asserted-by":"publisher","first-page":"830527","DOI":"10.3389\/fimmu.2021.830527","volume":"12","author":"M Shah","year":"2022","unstructured":"Shah M, Woo HG, Omicron. A heavily mutated SARS-CoV-2 variant exhibits stronger binding to ACE2 and potently escapes approved COVID-19 therapeutic antibodies. Front Immunol. 2022;12:830527. https:\/\/doi.org\/10.3389\/fimmu.2021.830527.","journal-title":"Front Immunol"},{"key":"3020_CR18","doi-asserted-by":"publisher","first-page":"4501","DOI":"10.1016\/j.csbj.2022.08.010","volume":"20","author":"AM Chaudhari","year":"2022","unstructured":"Chaudhari AM, Joshi M, Kumar D, Patel A, Lokhande KB, Krishnan A, et al. Evaluation of immune evasion in SARS-CoV-2 delta and Omicron variants. Comput Struct Biotechnol J. 2022;20:4501\u201316. https:\/\/doi.org\/10.1016\/j.csbj.2022.08.010.","journal-title":"Comput Struct Biotechnol J"},{"issue":"4","key":"3020_CR19","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.ccc.2021.05.003","volume":"37","author":"KE Swenson","year":"2021","unstructured":"Swenson KE, Swenson ER. Pathophysiology of acute respiratory distress syndrome and COVID-19 lung injury. Crit Care Clin. 2021;37(4):749\u201376. https:\/\/doi.org\/10.1016\/j.ccc.2021.05.003.","journal-title":"Crit Care Clin"},{"issue":"6","key":"3020_CR20","doi-asserted-by":"publisher","first-page":"7204","DOI":"10.18632\/oncotarget.23208","volume":"9","author":"L Chen","year":"2018","unstructured":"Chen L, Deng H, Cui H, Fang J, Zuo Z, Deng J, et al. Inflammatory responses and inflammation-associated diseases in organs. Oncotarget. 2018;9(6):7204\u201318. https:\/\/doi.org\/10.18632\/oncotarget.23208.","journal-title":"Oncotarget"},{"key":"3020_CR21","doi-asserted-by":"publisher","unstructured":"Hu Y, Zou J, Nguyen MD, Chang HC, Yeung J, Hao H, Shi P-Y, Ren P, Xie X. Comparative Analysis of Replication and Immune Evasion among SARS-CoV-2 Subvariants BA.2.86, JN.1, KP.2, and KP.3. mBio 2025, 16 (6), e03503-24. https:\/\/doi.org\/10.1128\/mbio.03503-24","DOI":"10.1128\/mbio.03503-24"},{"issue":"6","key":"3020_CR22","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/S2213-2600(21)00213-7","volume":"9","author":"D McGonagle","year":"2021","unstructured":"McGonagle D, Bridgewood C, Meaney JFM. A tricompartmental model of lung oxygenation disruption to explain pulmonary and systemic pathology in severe COVID-19. Lancet Respir Med. 2021;9(6):665\u201372. https:\/\/doi.org\/10.1016\/S2213-2600(21)00213-7.","journal-title":"Lancet Respir Med"},{"issue":"2","key":"3020_CR23","doi-asserted-by":"publisher","first-page":"L277","DOI":"10.1152\/ajplung.00195.2020","volume":"319","author":"F Potus","year":"2020","unstructured":"Potus F, Mai V, Lebret M, Malenfant S, Breton-Gagnon E, Lajoie AC, Boucherat O, Bonnet S, Provencher S. Novel insights on the pulmonary vascular consequences of COVID-19. Am J Physiol -Lung Cell Mol Physiol. 2020;319(2):L277\u201388. https:\/\/doi.org\/10.1152\/ajplung.00195.2020.","journal-title":"Am J Physiol -Lung Cell Mol Physiol"},{"issue":"2","key":"3020_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.239","volume":"4","author":"D Ao","year":"2023","unstructured":"Ao D, He X, Hong W, Wei X. The rapid rise of SARS-CoV\u20102 omicron subvariants with immune evasion properties: XBB.1.5 and BQ.1.1 subvariants. MedComm. 2023;4(2):e239. https:\/\/doi.org\/10.1002\/mco2.239.","journal-title":"MedComm"},{"issue":"1","key":"3020_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/v15010167","volume":"15","author":"S Chatterjee","year":"2023","unstructured":"Chatterjee S, Bhattacharya M, Nag S, Dhama K, Chakraborty CA. Detailed overview of SARS-CoV-2 omicron: its sub-variants, mutations and pathophysiology, clinical characteristics, immunological landscape, immune escape, and therapies. Viruses. 2023;15(1):167. https:\/\/doi.org\/10.3390\/v15010167.","journal-title":"Viruses"},{"key":"3020_CR26","doi-asserted-by":"publisher","unstructured":"Peacock TP, Brown JC, Zhou J, Thakur N, Sukhova K, Newman J, Kugathasan R, Yan AWC, Furnon W, De Lorenzo G, Cowton VM, Reuss D, Moshe M, Quantrill JL, Platt OK, Kaforou M, Patel AH, Palmarini M, Bailey D, Barclay WS. The altered entry pathway and antigenic distance of the SARS-CoV-2 Omicron variant map to separate domains of Spike protein. January 3, 2022. https:\/\/doi.org\/10.1101\/2021.12.31.474653","DOI":"10.1101\/2021.12.31.474653"},{"key":"3020_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.820864","volume":"13","author":"C Tornero","year":"2022","unstructured":"Tornero C, Pastor E, Garzando MDM, Ordu\u00f1a J, Forner MJ, Bocigas I, et al. Non-invasive vagus nerve stimulation for COVID-19: results from a randomized controlled trial (SAVIOR I). Front Neurol. 2022;13:820864. https:\/\/doi.org\/10.3389\/fneur.2022.820864.","journal-title":"Front Neurol"},{"issue":"7835","key":"3020_CR28","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41586-020-2601-5","volume":"587","author":"D Shin","year":"2020","unstructured":"Shin D, Mukherjee R, Grewe D, Bojkova D, Baek K, Bhattacharya A, Schulz L, Widera M, Mehdipour AR, Tascher G, Geurink PP, Wilhelm A, Van Der Noort H, Ovaa GJ, M\u00fcller H, Knobeloch S, Rajalingam K-P, Schulman K, Cinatl BA, Hummer J, Ciesek G, Dikic S. Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity. Nature. 2020;587(7835):657\u201362. https:\/\/doi.org\/10.1038\/s41586-020-2601-5.","journal-title":"Nature"},{"issue":"12","key":"3020_CR29","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.it.2020.10.004","volume":"41","author":"AG Harrison","year":"2020","unstructured":"Harrison AG, Lin T, Wang P. Mechanisms of SARS-CoV-2 transmission and pathogenesis. Trends Immunol. 2020;41(12):1100\u201315. https:\/\/doi.org\/10.1016\/j.it.2020.10.004.","journal-title":"Trends Immunol"},{"issue":"1","key":"3020_CR30","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41580-021-00418-x","volume":"23","author":"CB Jackson","year":"2022","unstructured":"Jackson CB, Farzan M, Chen B, Choe H. Mechanisms of SARS-CoV-2 entry into cells. Nat Rev Mol Cell Biol. 2022;23(1):3\u201320. https:\/\/doi.org\/10.1038\/s41580-021-00418-x.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"3020_CR31","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00428-021-03053-1","volume":"478","author":"H B\u00f6sm\u00fcller","year":"2021","unstructured":"B\u00f6sm\u00fcller H, Matter M, Fend F, Tzankov A. The pulmonary pathology of COVID-19. Virchows Arch. 2021;478(1):137\u201350. https:\/\/doi.org\/10.1007\/s00428-021-03053-1.","journal-title":"Virchows Arch"},{"key":"3020_CR32","volume-title":"StatPearls [Internet]","author":"A Aleem","year":"2025","unstructured":"Aleem A, Akbar Samad AB, Vaqar S. Emerging Variants of SARS-CoV-2 and Novel Therapeutics Against Coronavirus (COVID-19) [Updated 2023 May 8]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025."},{"key":"3020_CR33","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.24629","author":"AA Kinikar","year":"2022","unstructured":"Kinikar AA, Vartak S, Dawre R, Valvi C, Kamath P, Sonkawade N, Pawar S, Bhagat V, K. A, Nawale K, Deshmukh I, Das R, Kulkarni RK, Potdar V, Karyakarte R. Clinical profile and outcome of hospitalized confirmed cases of Omicron variant of SARS-CoV-2 among children in Pune, India. Cureus. 2022. https:\/\/doi.org\/10.7759\/cureus.24629.","journal-title":"Cureus"},{"issue":"4","key":"3020_CR34","doi-asserted-by":"publisher","first-page":"173","DOI":"10.4103\/atm.atm_7_23","volume":"18","author":"NN Alrajhi","year":"2023","unstructured":"Alrajhi NN, Post. -COVID-19 pulmonary fibrosis: an ongoing concern. Ann Thorac Med. 2023;18(4):173\u201381. https:\/\/doi.org\/10.4103\/atm.atm_7_23.","journal-title":"Ann Thorac Med"},{"issue":"3","key":"3020_CR35","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s41030-023-00226-y","volume":"9","author":"S Duong-Quy","year":"2023","unstructured":"Duong-Quy S, Vo-Pham-Minh T, Tran-Xuan Q, Huynh-Anh T, Vo-Van T, Vu-Tran-Thien Q, et al. Post-COVID-19 pulmonary fibrosis: facts\u2014challenges and futures: a narrative review. Pulm Ther. 2023;9(3):295\u2013307. https:\/\/doi.org\/10.1007\/s41030-023-00226-y.","journal-title":"Pulm Ther"},{"issue":"23","key":"3020_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/app142311048","volume":"14","author":"S Hall","year":"2024","unstructured":"Hall S, Berger G, Lehmann C. COVID-19 lung injury: unique and familiar aspects of pathophysiology. Appl Sci. 2024;14(23):11048. https:\/\/doi.org\/10.3390\/app142311048.","journal-title":"Appl Sci"},{"key":"3020_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ensci.2023.100485","volume":"33","author":"G Molaverdi","year":"2023","unstructured":"Molaverdi G, Kamal Z, Safavi M, Shafiee A, Mozhgani S-H, Ghobadi MZ, et al. Neurological complications after COVID-19: a narrative review. eNeurolSci. 2023;33:100485. https:\/\/doi.org\/10.1016\/j.ensci.2023.100485.","journal-title":"eNeurolSci"},{"issue":"6","key":"3020_CR38","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.4103\/1673-5374.327323","volume":"17","author":"M Haidar","year":"2022","unstructured":"Haidar M, Shakkour Z, Reslan M, Al-Haj N, Chamoun P, Habashy K, et al. SARS-CoV-2 involvement in central nervous system tissue damage. Neural Regen Res. 2022;17(6):1228. https:\/\/doi.org\/10.4103\/1673-5374.327323.","journal-title":"Neural Regen Res"},{"key":"3020_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2024.1393371","volume":"15","author":"ZS Zheng","year":"2024","unstructured":"Zheng ZS, Simonian N, Wang J, Rosario ER. Transcutaneous vagus nerve stimulation improves long COVID symptoms in a female cohort: a pilot study. Front Neurol. 2024;15:1393371. https:\/\/doi.org\/10.3389\/fneur.2024.1393371.","journal-title":"Front Neurol"},{"key":"3020_CR40","unstructured":"Respiratory Muscle. Training. Physiopedia. https:\/\/www.physio-pedia.com\/Respiratory_Muscle_Training (accessed 2025-07-04)."},{"issue":"11","key":"3020_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10112807","volume":"10","author":"K Villelabeitia-Jaureguizar","year":"2022","unstructured":"Villelabeitia-Jaureguizar K, Calvo-Lobo C, Rodr\u00edguez-Sanz D, Vicente-Campos D, Castro-Portal JA, L\u00f3pez-Ca\u00f1adas M, et al. Low intensity respiratory muscle training in COVID-19 patients after invasive mechanical ventilation: a retrospective case-series study. Biomedicines. 2022;10(11):2807. https:\/\/doi.org\/10.3390\/biomedicines10112807.","journal-title":"Biomedicines"},{"issue":"1","key":"3020_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-022-04021-0","volume":"26","author":"Y Wang","year":"2022","unstructured":"Wang Y, Zhong M, Dong M, Song J, Zheng Y, Wu W, et al. Prone positioning improves ventilation\u2013perfusion matching assessed by electrical impedance tomography in patients with ARDS: a prospective physiological study. Crit Care. 2022;26(1):154. https:\/\/doi.org\/10.1186\/s13054-022-04021-0.","journal-title":"Crit Care"},{"issue":"15","key":"3020_CR43","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.3748\/wjg.v27.i15.1531","volume":"27","author":"FEM Ali","year":"2021","unstructured":"Ali FEM, Mohammedsaleh ZM, Ali MM, Ghogar OM. Impact of cytokine storm and systemic inflammation on liver impairment patients infected by SARS-CoV-2: prospective therapeutic challenges. World J Gastroenterol. 2021;27(15):1531\u201352. https:\/\/doi.org\/10.3748\/wjg.v27.i15.1531.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"3020_CR44","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.247","volume":"4","author":"S Sarkar","year":"2023","unstructured":"Sarkar S, Karmakar S, Basu M, Ghosh P, Ghosh MK. Neurological damages in COVID-19 patients: mechanisms and preventive interventions. MedComm. 2023;4(2):e247. https:\/\/doi.org\/10.1002\/mco2.247.","journal-title":"MedComm"},{"key":"3020_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.667036","volume":"15","author":"S Mastitskaya","year":"2021","unstructured":"Mastitskaya S, Thompson N, Holder D. Selective vagus nerve stimulation as a therapeutic approach for the treatment of ARDS: a rationale for neuro-immunomodulation in COVID-19 disease. Front Neurosci. 2021;15:667036. https:\/\/doi.org\/10.3389\/fnins.2021.667036.","journal-title":"Front Neurosci"},{"key":"3020_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.856376","volume":"13","author":"Y Cai","year":"2022","unstructured":"Cai Y, Liu J, Wang B, Sun M, Yang H. Microglia in the neuroinflammatory pathogenesis of Alzheimer\u2019s disease and related therapeutic targets. Front Immunol. 2022;13:856376. https:\/\/doi.org\/10.3389\/fimmu.2022.856376.","journal-title":"Front Immunol"},{"key":"3020_CR47","doi-asserted-by":"publisher","unstructured":"Deshwal S, Dhiman N, Sandhir R. Blood brain barrier disruption following COVID-19 infection and neurological manifestations. COVID-19 in alzheimer\u2019s disease and dementia. Elsevier; 2023. pp. 171\u2013201. https:\/\/doi.org\/10.1016\/B978-0-443-15256-6.00005-2.","DOI":"10.1016\/B978-0-443-15256-6.00005-2"},{"key":"3020_CR48","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.bbi.2015.08.011","volume":"51","author":"K Ramirez","year":"2016","unstructured":"Ramirez K, Niraula A, Sheridan JF. Gabaergic modulation with classical benzodiazepines prevent stress-induced neuro-immune dysregulation and behavioral alterations. Brain Behav Immun. 2016;51:154\u201368. https:\/\/doi.org\/10.1016\/j.bbi.2015.08.011.","journal-title":"Brain Behav Immun"},{"issue":"15","key":"3020_CR49","doi-asserted-by":"publisher","first-page":"5667","DOI":"10.1007\/s00018-021-03881-z","volume":"78","author":"AK Bhandage","year":"2021","unstructured":"Bhandage AK, Barragan A, GABAergic. Signaling by cells of the immune system: more the rule than the exception. Cell Mol Life Sci. 2021;78(15):5667\u201379. https:\/\/doi.org\/10.1007\/s00018-021-03881-z.","journal-title":"Cell Mol Life Sci"},{"key":"3020_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.dscb.2023.100074","volume":"10","author":"K Otani","year":"2023","unstructured":"Otani K, Fukushima H, Matsuishi K. COVID-19 delirium and encephalopathy: pathophysiology assumed in the first 3 years of the ongoing pandemic. Brain Disorders. 2023;10:100074. https:\/\/doi.org\/10.1016\/j.dscb.2023.100074.","journal-title":"Brain Disorders"},{"key":"3020_CR51","doi-asserted-by":"publisher","first-page":"100189","DOI":"10.1016\/j.ahjo.2022.100189","volume":"20","author":"MM Kerolos","year":"2022","unstructured":"Kerolos MM, Ruge M, Gill A, Planek MI, Volgman AS, Du-Fay-De-Lavallaz JM, Gomez JMD, Suboc TM, Williams KA, Abusin S. Clinical outcomes of COVID-19 infection in patients with Pre-Existing cardiovascular disease. Am Heart J Plus Cardiol Res Pract. 2022;20:100189. https:\/\/doi.org\/10.1016\/j.ahjo.2022.100189.","journal-title":"Am Heart J Plus Cardiol Res Pract"},{"key":"3020_CR52","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.38576","author":"O Tolu-Akinnawo","year":"2023","unstructured":"Tolu-Akinnawo O, Adusei Poku F, Elimihele T, League M, Adkins CF, Okafor H. Acute cardiovascular complications of COVID-19: A systematic review. Cureus. 2023. https:\/\/doi.org\/10.7759\/cureus.38576.","journal-title":"Cureus"},{"key":"3020_CR53","volume-title":"StatPearls","author":"I Basu-Ray","year":"2025","unstructured":"Basu-Ray I, Almaddah Nk, Vaqar S, Soos MP. Cardiac Manifestations of Coronavirus (COVID-19). In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2025."},{"issue":"1","key":"3020_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s12985-022-01814-1","volume":"19","author":"S Montazersaheb","year":"2022","unstructured":"Montazersaheb S, Hosseiniyan Khatibi SM, Hejazi MS, Tarhriz V, Farjami A, Ghasemian Sorbeni F, et al. COVID-19 infection: an overview on cytokine storm and related interventions. Virol J. 2022;19(1):92. https:\/\/doi.org\/10.1186\/s12985-022-01814-1.","journal-title":"Virol J"},{"issue":"1","key":"3020_CR55","doi-asserted-by":"publisher","DOI":"10.31083\/j.rcm2401028","volume":"24","author":"NY Kusumawardhani","year":"2023","unstructured":"Kusumawardhani NY, Putra ICS, Kamarullah W, Afrianti R, Pramudyo M, Iqbal M, et al. Cardiovascular disease in post-acute COVID-19 syndrome: a comprehensive review of pathophysiology and diagnosis approach. Rev Cardiovasc Med. 2023;24(1):28. https:\/\/doi.org\/10.31083\/j.rcm2401028.","journal-title":"Rev Cardiovasc Med"},{"issue":"2","key":"3020_CR56","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3390\/hematolrep15020024","volume":"15","author":"H Sutanto","year":"2023","unstructured":"Sutanto H, Soegiarto G. Risk of thrombosis during and after a SARS-CoV-2 infection: pathogenesis, diagnostic approach, and management. Hematol Rep. 2023;15(2):225\u201343. https:\/\/doi.org\/10.3390\/hematolrep15020024.","journal-title":"Hematol Rep"},{"issue":"1","key":"3020_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-023-00337-1","volume":"12","author":"P Huang","year":"2023","unstructured":"Huang P, Zhang L-Y, Tan Y-Y, Chen S-D. Links between COVID-19 and Parkinson\u2019s disease\/Alzheimer\u2019s disease: reciprocal impacts, medical care strategies and underlying mechanisms. Transl Neurodegener. 2023;12(1):5. https:\/\/doi.org\/10.1186\/s40035-023-00337-1.","journal-title":"Transl Neurodegener"},{"issue":"1","key":"3020_CR58","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.amjms.2020.10.002","volume":"361","author":"W-T Chang","year":"2021","unstructured":"Chang W-T, Toh HS, Liao C-T, Yu W-L. Cardiac involvement of COVID-19: a comprehensive review. Am J Med Sci. 2021;361(1):14\u201322. https:\/\/doi.org\/10.1016\/j.amjms.2020.10.002.","journal-title":"Am J Med Sci"},{"issue":"2","key":"3020_CR59","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3748\/wjg.v29.i2.257","volume":"29","author":"I Papagiouvanni","year":"2023","unstructured":"Papagiouvanni I, Kotoulas S-C, Pataka A, Spyratos DG, Porpodis K, Boutou AK, et al. COVID-19 and liver injury: an ongoing challenge. World J Gastroenterol. 2023;29(2):257\u201371. https:\/\/doi.org\/10.3748\/wjg.v29.i2.257.","journal-title":"World J Gastroenterol"},{"issue":"10","key":"3020_CR60","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.12998\/wjcc.v11.i10.2189","volume":"11","author":"M Helou","year":"2023","unstructured":"Helou M, Nasr J, El Osta N, Jabbour E, Husni R. Liver manifestations in COVID-19 patients: a review article. World J Clin Cases. 2023;11(10):2189\u2013200. https:\/\/doi.org\/10.12998\/wjcc.v11.i10.2189.","journal-title":"World J Clin Cases"},{"issue":"9","key":"3020_CR61","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.4254\/wjh.v13.i9.1143","volume":"13","author":"GX Ortiz","year":"2021","unstructured":"Ortiz GX, Lenhart G, Becker MW, Schwambach KH, Tovo CV, Blatt CR. Drug-induced liver injury and COVID-19: a review for clinical practice. World J Hepatol. 2021;13(9):1143\u201353. https:\/\/doi.org\/10.4254\/wjh.v13.i9.1143.","journal-title":"World J Hepatol"},{"issue":"6","key":"3020_CR62","doi-asserted-by":"publisher","first-page":"435","DOI":"10.5501\/wjv.v11.i6.435","volume":"11","author":"W Wongtanasarasin","year":"2022","unstructured":"Wongtanasarasin W. Cholestatic liver injury: a rare but fatal complication during and after COVID-19 infection. World J Virol. 2022;11(6):435\u201342. https:\/\/doi.org\/10.5501\/wjv.v11.i6.435.","journal-title":"World J Virol"},{"issue":"2","key":"3020_CR63","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3748\/wjg.v29.i2.241","volume":"29","author":"S-W Zhao","year":"2023","unstructured":"Zhao S-W, Li Y-M, Li Y-L, Su C. Liver injury in COVID-19: clinical features, potential mechanisms, risk factors and clinical treatments. World J Gastroenterol. 2023;29(2):241\u201356. https:\/\/doi.org\/10.3748\/wjg.v29.i2.241.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"3020_CR64","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/path.5471","volume":"251","author":"AR Bourgonje","year":"2020","unstructured":"Bourgonje AR, Abdulle AE, Timens W, Hillebrands J, Navis GJ, Gordijn SJ, Bolling MC, Dijkstra G, Voors AA, Osterhaus AD, Van Der Voort PH, Mulder DJ, Van Goor H. Angiotensin-converting enzyme 2 (ACE2), SARS\u2010CoV \u20102 and the pathophysiology of coronavirus disease 2019 (COVID \u201019). J Pathol. 2020;251(3):228\u201348. https:\/\/doi.org\/10.1002\/path.5471.","journal-title":"J Pathol"},{"issue":"6","key":"3020_CR65","doi-asserted-by":"publisher","DOI":"10.3390\/v15061231","volume":"15","author":"SSK Durairajan","year":"2023","unstructured":"Durairajan SSK, Singh AK, Saravanan UB, Namachivayam M, Radhakrishnan M, Huang J-D, et al. Gastrointestinal manifestations of SARS-CoV-2: transmission, pathogenesis, immunomodulation, microflora dysbiosis, and clinical implications. Viruses. 2023;15(6):1231. https:\/\/doi.org\/10.3390\/v15061231.","journal-title":"Viruses"},{"issue":"8","key":"3020_CR66","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1586\/17474124.2015.1057122","volume":"9","author":"K Brandl","year":"2015","unstructured":"Brandl K, Schnabl B. Is intestinal inflammation linking dysbiosis to gut barrier dysfunction during liver disease? Expert Rev Gastroenterol Hepatol. 2015;9(8):1069\u201376. https:\/\/doi.org\/10.1586\/17474124.2015.1057122.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"3020_CR67","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2024.1384939","volume":"14","author":"ST Raj","year":"2024","unstructured":"Raj ST, Bruce AW, Anbalagan M, Srinivasan H, Chinnappan S, Rajagopal M, et al. COVID-19 influenced gut dysbiosis, post-acute sequelae, immune regulation, and therapeutic regimens. Front Cell Infect Microbiol. 2024;14:1384939. https:\/\/doi.org\/10.3389\/fcimb.2024.1384939.","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"3020_CR68","doi-asserted-by":"publisher","first-page":"75","DOI":"10.34172\/mejdd.2021.208","volume":"13","author":"A Asghari","year":"2021","unstructured":"Asghari A, Adeli SH, Vafaeimanesh J, Bagheri H, Riahi M, Mirdamadi M. Intestinal ischemia due to mesenteric vascular thrombosis in a patient with positive SARS-Cov-2 RNA without primary pulmonary symptom: a case report. Middle East J Dig Dis. 2021;13(1):75\u20139. https:\/\/doi.org\/10.34172\/mejdd.2021.208.","journal-title":"Middle East J Dig Dis"},{"key":"3020_CR69","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2021.669808","volume":"8","author":"J Peng","year":"2021","unstructured":"Peng J, Zhang M, Yao G, Kwok L-Y, Zhang W. Probiotics as adjunctive treatment for patients contracted COVID-19: current understanding and future needs. Front Nutr. 2021;8:669808. https:\/\/doi.org\/10.3389\/fnut.2021.669808.","journal-title":"Front Nutr"},{"key":"3020_CR70","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2025.1537456","volume":"15","author":"SW Smail","year":"2025","unstructured":"Smail SW, Albarzinji N, Salih RH, Taha KO, Hirmiz SM, Ismael HM, et al. Microbiome dysbiosis in SARS-CoV-2 infection: implication for pathophysiology and management strategies of COVID-19. Front Cell Infect Microbiol. 2025;15:1537456. https:\/\/doi.org\/10.3389\/fcimb.2025.1537456.","journal-title":"Front Cell Infect Microbiol"},{"issue":"8","key":"3020_CR71","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1016\/j.ekir.2020.05.008","volume":"5","author":"GE VanNoy","year":"2020","unstructured":"VanNoy GE, Wojcik MH, Genetti CA, Mullen TE, Agrawal PB, Stein DR. Reconsidering genetic testing for neonatal polycystic kidney disease. Kidney Int Rep. 2020;5(8):1316\u20139. https:\/\/doi.org\/10.1016\/j.ekir.2020.05.008.","journal-title":"Kidney Int Rep"},{"issue":"8","key":"3020_CR72","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.ekir.2020.06.013","volume":"5","author":"SY Robbins-Juarez","year":"2020","unstructured":"Robbins-Juarez SY, Qian L, King KL, Stevens JS, Husain SA, Radhakrishnan J, et al. Outcomes for patients with COVID-19 and acute kidney injury: a systematic review and meta-analysis. Kidney Int Rep. 2020;5(8):1149\u201360. https:\/\/doi.org\/10.1016\/j.ekir.2020.06.013.","journal-title":"Kidney Int Rep"},{"issue":"11","key":"3020_CR73","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/s41581-021-00452-0","volume":"17","author":"M Legrand","year":"2021","unstructured":"Legrand M, Bell S, Forni L, Joannidis M, Koyner JL, Liu K, et al. Pathophysiology of COVID-19-associated acute kidney injury. Nat Rev Nephrol. 2021;17(11):751\u201364. https:\/\/doi.org\/10.1038\/s41581-021-00452-0.","journal-title":"Nat Rev Nephrol"},{"issue":"4","key":"3020_CR74","doi-asserted-by":"publisher","DOI":"10.23750\/abm.v91i4.10380","volume":"91","author":"JA Leon-Abarca","year":"2020","unstructured":"Leon-Abarca JA, Memon RS, Rehan B, Iftikhar M, Chatterjee A. The impact of COVID-19 in diabetic kidney disease and chronic kidney disease: a population-based study. Acta Bio Med Atenei Parmensis. 2020;91(4):e2020161. https:\/\/doi.org\/10.23750\/abm.v91i4.10380.","journal-title":"Acta Bio Med Atenei Parmensis"},{"key":"3020_CR75","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.ijid.2021.01.023","volume":"104","author":"AD Elec","year":"2021","unstructured":"Elec AD, Oltean M, Goldis P, Cismaru C, Lupse M, Muntean A, et al. COVID-19 after kidney transplantation: early outcomes and renal function following antiviral treatment. Int J Infect Dis. 2021;104:426\u201332. https:\/\/doi.org\/10.1016\/j.ijid.2021.01.023.","journal-title":"Int J Infect Dis"},{"key":"3020_CR76","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.trsl.2021.11.003","volume":"241","author":"JD Long","year":"2022","unstructured":"Long JD, Strohbehn I, Sawtell R, Bhattacharyya R, Sise ME. COVID-19 survival and its impact on chronic kidney disease. Transl Res. 2022;241:70\u201382. https:\/\/doi.org\/10.1016\/j.trsl.2021.11.003.","journal-title":"Transl Res"},{"issue":"4","key":"3020_CR77","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1021\/acscentsci.1c00120","volume":"7","author":"Y Li","year":"2021","unstructured":"Li Y, Tenchov R, Smoot J, Liu C, Watkins S, Zhou Q. A comprehensive review of the global efforts on COVID-19 vaccine development. ACS Cent Sci. 2021;7(4):512\u201333. https:\/\/doi.org\/10.1021\/acscentsci.1c00120.","journal-title":"ACS Cent Sci"},{"issue":"10323","key":"3020_CR78","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S0140-6736(22)00017-4","volume":"399","author":"N Wolter","year":"2022","unstructured":"Wolter N, Jassat W, Walaza S, Welch R, Moultrie H, Groome M, et al. Early assessment of the clinical severity of the SARS-CoV-2 Omicron variant in South Africa: a data linkage study. Lancet. 2022;399(10323):437\u201346. https:\/\/doi.org\/10.1016\/S0140-6736(22)00017-4.","journal-title":"Lancet"},{"issue":"10","key":"3020_CR79","doi-asserted-by":"publisher","first-page":"5033","DOI":"10.1002\/jmv.27908","volume":"94","author":"GCK Mak","year":"2022","unstructured":"Mak GCK, Lau SSY, Wong KKY, Lau C, Ng KHL, Lam ETK, et al. Analytical sensitivity of the rapid antigen test kits for detection of SARS-CoV\u20102 Omicron variant BA.2 sublineage. J Med Virol. 2022;94(10):5033\u20137. https:\/\/doi.org\/10.1002\/jmv.27908.","journal-title":"J Med Virol"},{"key":"3020_CR80","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2022-071215","volume":"378","author":"E Schuit","year":"2022","unstructured":"Schuit E, Venekamp RP, Hooft L, Veldhuijzen IK, Van Den Bijllaardt W, Pas SD, et al. Diagnostic accuracy of Covid-19 rapid antigen tests with unsupervised self-sampling in people with symptoms in the Omicron period: cross sectional study. BMJ. 2022;e071215. https:\/\/doi.org\/10.1136\/bmj-2022-071215.","journal-title":"BMJ"},{"issue":"4","key":"3020_CR81","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1002\/jmv.26691","volume":"93","author":"A Garg","year":"2021","unstructured":"Garg A, Ghoshal U, Patel SS, Singh DV, Arya AK, Vasanth S, et al. Evaluation of seven commercial RT-PCR kits for COVID\u201019 testing in pooled clinical specimens. J Med Virol. 2021;93(4):2281\u20136. https:\/\/doi.org\/10.1002\/jmv.26691.","journal-title":"J Med Virol"},{"issue":"3","key":"3020_CR82","doi-asserted-by":"publisher","first-page":"100","DOI":"10.15585\/mmwr.mm7003e3","volume":"70","author":"JL Prince-Guerra","year":"2021","unstructured":"Prince-Guerra JL, Almendares O, Nolen LD, Gunn JKL, Dale AP, Buono SA, et al. Evaluation of Abbott BinaxNOW rapid antigen test for SARS-CoV-2 infection at two community-based testing sites \u2014 Pima County, Arizona, November 3\u201317, 2020. MMWR Morb Mortal Wkly Rep. 2021;70(3):100\u20135. https:\/\/doi.org\/10.15585\/mmwr.mm7003e3.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"3020_CR83","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-00852-z","volume":"11","author":"J Singh","year":"2021","unstructured":"Singh J, Yadav AK, Pakhare A, Kulkarni P, Lokhande L, Soni P, et al. Comparative analysis of the diagnostic performance of five commercial COVID-19 qRT PCR kits used in India. Sci Rep. 2021;11(1):22013. https:\/\/doi.org\/10.1038\/s41598-021-00852-z.","journal-title":"Sci Rep"},{"issue":"1","key":"3020_CR84","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00011-021-01520-8","volume":"71","author":"WH Faour","year":"2022","unstructured":"Faour WH, Choaib A, Issa E, Choueiry FE, Shbaklo K, Alhajj M, et al. Mechanisms of COVID-19-induced kidney injury and current pharmacotherapies. Inflamm Res. 2022;71(1):39\u201356. https:\/\/doi.org\/10.1007\/s00011-021-01520-8.","journal-title":"Inflamm Res"},{"key":"3020_CR85","doi-asserted-by":"publisher","DOI":"10.18502\/pbr.v7i2.7359","author":"P Saberi-Hasanabadi","year":"2021","unstructured":"Saberi-Hasanabadi P, Mohammadi H. COVID-19 pandemic: management and challenges. Pharm Biomed Res. 2021. https:\/\/doi.org\/10.18502\/pbr.v7i2.7359.","journal-title":"Pharm Biomed Res"},{"issue":"1","key":"3020_CR86","doi-asserted-by":"publisher","DOI":"10.1002\/emp2.12375","volume":"2","author":"A Adeyinka","year":"2021","unstructured":"Adeyinka A, Bailey K, Pierre L, Kondamudi N. COVID 19 infection: pediatric perspectives. JACEP Open. 2021;2(1):e12375. https:\/\/doi.org\/10.1002\/emp2.12375.","journal-title":"JACEP Open"},{"issue":"10335","key":"3020_CR87","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1016\/S0140-6736(22)00327-0","volume":"399","author":"C Menni","year":"2022","unstructured":"Menni C, Valdes AM, Polidori L, Antonelli M, Penamakuri S, Nogal A, et al. Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of Omicron and delta variant dominance: a prospective observational study from the ZOE COVID study. Lancet. 2022;399(10335):1618\u201324. https:\/\/doi.org\/10.1016\/S0140-6736(22)00327-0.","journal-title":"Lancet"},{"issue":"1","key":"3020_CR88","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s12016-021-08848-3","volume":"64","author":"B Oronsky","year":"2021","unstructured":"Oronsky B, Larson C, Hammond TC, Oronsky A, Kesari S, Lybeck M, et al. A review of persistent post-COVID syndrome (PPCS). Clin Rev Allergy Immunol. 2021;64(1):66\u201374. https:\/\/doi.org\/10.1007\/s12016-021-08848-3.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"628","key":"3020_CR89","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abl7430","volume":"14","author":"WA Fischer","year":"2022","unstructured":"Fischer WA, Eron JJ, Holman W, Cohen MS, Fang L, Szewczyk LJ, et al. A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus. Sci Transl Med. 2022;14(628):eabl7430. https:\/\/doi.org\/10.1126\/scitranslmed.abl7430.","journal-title":"Sci Transl Med"},{"key":"3020_CR90","unstructured":"What Omicron\u2019s BA.4 and BA.5 variants mean for the pandemic. https:\/\/www.nature.com\/articles\/d41586-022-01730-y (accessed 2025-07-04)."},{"key":"3020_CR91","doi-asserted-by":"publisher","first-page":"653516","DOI":"10.3389\/fmed.2021.653516","volume":"8","author":"F Salamanna","year":"2021","unstructured":"Salamanna F, Veronesi F, Martini L, Landini MP, Fini M, Post. -COVID-19 syndrome: the persistent symptoms at the Post-Viral stage of the Disease. A systematic review of the current data. Front Med. 2021;8:653516. https:\/\/doi.org\/10.3389\/fmed.2021.653516.","journal-title":"Front Med"},{"issue":"9","key":"3020_CR92","doi-asserted-by":"publisher","DOI":"10.3390\/biology12091267","volume":"12","author":"M Andre","year":"2023","unstructured":"Andre M, Lau L-S, Pokharel MD, Ramelow J, Owens F, Souchak J, et al. From alpha to omicron: how different variants of concern of the SARS-coronavirus-2 impacted the world. Biology. 2023;12(9):1267. https:\/\/doi.org\/10.3390\/biology12091267.","journal-title":"Biology"},{"issue":"10","key":"3020_CR93","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1080\/23744235.2021.1924397","volume":"53","author":"SJ Yong","year":"2021","unstructured":"Yong SJ, Long. COVID or Post-COVID-19 syndrome: putative Pathophysiology, risk Factors, and treatments. Infect Dis. 2021;53(10):737\u201354. https:\/\/doi.org\/10.1080\/23744235.2021.1924397.","journal-title":"Infect Dis"},{"issue":"11","key":"3020_CR94","doi-asserted-by":"publisher","first-page":"835","DOI":"10.2217\/fvl-2021-0212","volume":"17","author":"R Dowran","year":"2022","unstructured":"Dowran R, Damavandi AR, Azad TM. Reinfection and reactivation of SARS-CoV-2. Future Virol. 2022;17(11):835\u201344. https:\/\/doi.org\/10.2217\/fvl-2021-0212.","journal-title":"Future Virol"},{"issue":"1","key":"3020_CR95","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-79254-w","volume":"14","author":"Y Cheng","year":"2024","unstructured":"Cheng Y, Zhou Y, Chen Y, Xie W, Meng J, Shen D, et al. Rapid detection of the SARS-CoV-2 Omicron variants based on high-resolution melting curve analysis. Sci Rep. 2024;14(1):28227. https:\/\/doi.org\/10.1038\/s41598-024-79254-w.","journal-title":"Sci Rep"},{"issue":"9","key":"3020_CR96","doi-asserted-by":"publisher","DOI":"10.3390\/v17091177","volume":"17","author":"LD Patterson","year":"2025","unstructured":"Patterson LD, Elsharkawy A, Jahantigh HR, Nabi Z, Stone S, Kumar M. Pathogenicity of SARS-CoV-2 Omicron subvariants JN.1, KP.2, and EG.5.1 in K18-hACE2 transgenic mice. Viruses. 2025;17(9):1177. https:\/\/doi.org\/10.3390\/v17091177.","journal-title":"Viruses"},{"issue":"1","key":"3020_CR97","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-28715-9","volume":"13","author":"S Wacharapluesadee","year":"2023","unstructured":"Wacharapluesadee S, Hirunpatrawong P, Petcharat S, Torvorapanit P, Jitsatja A, Thippamom N, et al. Simultaneous detection of Omicron and other SARS-CoV-2 variants by multiplex PCR MassARRAY technology. Sci Rep. 2023;13(1):2089. https:\/\/doi.org\/10.1038\/s41598-023-28715-9.","journal-title":"Sci Rep"},{"issue":"1","key":"3020_CR98","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms11010191","volume":"11","author":"M Brandolini","year":"2023","unstructured":"Brandolini M, Gatti G, Grumiro L, Zannoli S, Arfilli V, Cricca M, et al. Omicron sub-lineage BA.5 and recombinant XBB evasion from antibody neutralisation in BNT162b2 vaccine recipients. Microorganisms. 2023;11(1):191. https:\/\/doi.org\/10.3390\/microorganisms11010191.","journal-title":"Microorganisms"},{"issue":"10","key":"3020_CR99","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11101533","volume":"11","author":"AA Pochtovyi","year":"2023","unstructured":"Pochtovyi AA, Kustova DD, Siniavin AE, Dolzhikova IV, Shidlovskaya EV, Shpakova OG, et al. In vitro efficacy of antivirals and monoclonal antibodies against SARS-CoV-2 Omicron lineages XBB.1.9.1, XBB.1.9.3, XBB.1.5, XBB.1.16, XBB.2.4, BQ.1.1.45, CH.1.1, and CL.1. Vaccines. 2023;11(10):1533. https:\/\/doi.org\/10.3390\/vaccines11101533.","journal-title":"Vaccines"},{"key":"3020_CR100","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2024.110067","volume":"595","author":"J Lee","year":"2024","unstructured":"Lee J, Naoe Y, Bang U, Nakagama Y, Saito A, Kido Y, et al. Neutralization sensitivity of SARS-CoV-2 Omicron variants FL.1 and GE.1 by therapeutic antibodies and XBB sera. Virology. 2024;595:110067. https:\/\/doi.org\/10.1016\/j.virol.2024.110067.","journal-title":"Virology"},{"issue":"5","key":"3020_CR101","doi-asserted-by":"publisher","first-page":"e28788","DOI":"10.1002\/jmv.28788","volume":"95","author":"Y Sakai-Tagawa","year":"2023","unstructured":"Sakai-Tagawa Y, Yamayoshi S, Halfmann PJ, Wilson N, Bobholz M, Vuyk WC, Wei W, Ries H, O\u2019Connor DH, Friedrich TC, Sordillo EM, Van Bakel H, Simon V, Kawaoka Y. Sensitivity of rapid antigen tests for Omicron subvariants of SARS\u2010CoV\u20102. J Med Virol. 2023;95(5):e28788. https:\/\/doi.org\/10.1002\/jmv.28788.","journal-title":"J Med Virol"},{"issue":"1","key":"3020_CR102","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms11010191","volume":"11","author":"M Brandolini","year":"2023","unstructured":"Brandolini M, Gatti G, Grumiro L, Zannoli S, Arfilli V, Cricca M, et al. Omicron sub-lineage BA.5 and recombinant XBB evasion from antibody neutralisation in BNT162b2 vaccine recipients. Microorganisms. 2023;11(1):191. https:\/\/doi.org\/10.3390\/microorganisms11010191.","journal-title":"Microorganisms"},{"key":"3020_CR103","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113522","volume":"154","author":"M Dhawan","year":"2022","unstructured":"Dhawan M, Saied AA, Mitra S, Alhumaydhi FA, Emran TB, Wilairatana P. Omicron variant (B.1.1.529) and its sublineages: what do we know so far amid the emergence of recombinant variants of SARS-CoV-2? Biomed Pharmacother. 2022;154:113522. https:\/\/doi.org\/10.1016\/j.biopha.2022.113522.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"3020_CR104","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02437-y","volume":"10","author":"R-R Chen","year":"2025","unstructured":"Chen R-R, Cao G-P, Song X-D, Lu M, Wang M-M, Wang X-J, et al. Neutralizing antibody durability and SARS-CoV-2 infection in older adults six months after XBB-containing vaccine booster. Signal Transduct Target Ther. 2025;10(1):336. https:\/\/doi.org\/10.1038\/s41392-025-02437-y.","journal-title":"Signal Transduct Target Ther"},{"issue":"7","key":"3020_CR105","doi-asserted-by":"publisher","first-page":"e012328","DOI":"10.1136\/bmjgh-2023-012328","volume":"8","author":"P Relan","year":"2023","unstructured":"Relan P, Motaze NV, Kothari K, Askie L, Le Polain O, Van Kerkhove MD, Diaz J, Tirupakuzhi Vijayaraghavan BK. Severity and outcomes of Omicron variant of SARS-CoV-2 compared to delta variant and severity of Omicron sublineages: A systematic review and metanalysis. BMJ Glob Health. 2023;8(7):e012328. https:\/\/doi.org\/10.1136\/bmjgh-2023-012328.","journal-title":"BMJ Glob Health"},{"issue":"6","key":"3020_CR106","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nri3843","volume":"15","author":"SS Evans","year":"2015","unstructured":"Evans SS, Repasky EA, Fisher DT. Fever and the thermal regulation of immunity: the immune system feels the heat. Nat Rev Immunol. 2015;15(6):335\u201349. https:\/\/doi.org\/10.1038\/nri3843.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"3020_CR107","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.idc.2022.11.001","volume":"37","author":"Y Abul","year":"2023","unstructured":"Abul Y, Leeder C, Gravenstein S. Epidemiology and clinical presentation of COVID-19 in older adults. Infect Dis Clin North Am. 2023;37(1):1\u201326. https:\/\/doi.org\/10.1016\/j.idc.2022.11.001.","journal-title":"Infect Dis Clin North Am"},{"key":"3020_CR108","volume-title":"StatPearls","author":"EV Osilla","year":"2025","unstructured":"Osilla EV, Marsidi JL, Shumway KR, Sharma S. Physiology. Temperature Regulation. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2025."},{"issue":"1","key":"3020_CR109","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.immuni.2018.11.013","volume":"50","author":"C Lin","year":"2019","unstructured":"Lin C, Zhang Y, Zhang K, Zheng Y, Lu L, Chang H, et al. Fever promotes T lymphocyte trafficking via a thermal sensory pathway involving heat shock protein 90 and \u03b14 integrins. Immunity. 2019;50(1):137-151.e6. https:\/\/doi.org\/10.1016\/j.immuni.2018.11.013.","journal-title":"Immunity"},{"issue":"12","key":"3020_CR110","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1158\/2326-6066.CIR-23-1075","volume":"12","author":"Y Du","year":"2024","unstructured":"Du Y, Salehi-Rad R, Zhang T, Crosson WP, Abascal J, Chen D, et al. Hyper-interferon sensitive influenza induces adaptive immune responses and overcomes resistance to anti\u2013PD-1 in murine non\u2013small cell lung cancer. Cancer Immunol Res. 2024;12(12):1765\u201379. https:\/\/doi.org\/10.1158\/2326-6066.CIR-23-1075.","journal-title":"Cancer Immunol Res"},{"issue":"8","key":"3020_CR111","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a009720","volume":"3","author":"BM Button","year":"2013","unstructured":"Button BM, Button B. Structure and function of the mucus clearance system of the lung. Cold Spring Harb Perspect Med. 2013;3(8):a009720\u2013009720. https:\/\/doi.org\/10.1101\/cshperspect.a009720.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"3020_CR112","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.23299.2","volume":"9","author":"M Cohen","year":"2020","unstructured":"Cohen M. Turning up the heat on COVID-19: heat as a therapeutic intervention. F1000Res. 2020;9:292. https:\/\/doi.org\/10.12688\/f1000research.23299.2.","journal-title":"F1000Res"},{"key":"3020_CR113","doi-asserted-by":"publisher","unstructured":"Nawar T, Morjaria S, Kaltsas A, Patel D, Perez-Johnston R, Daniyan AF, Mailankody S, Parameswaran R. Granulocyte\u2010colony stimulating factor in COVID \u201019: is it stimulating more than just the bone marrow? Am J Hematol. 2020;95(8). https:\/\/doi.org\/10.1002\/ajh.25870.","DOI":"10.1002\/ajh.25870"},{"key":"3020_CR114","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110959","volume":"133","author":"T Behl","year":"2021","unstructured":"Behl T, Kumar K, Brisc C, Rus M, Nistor-Cseppento DC, Bustea C, et al. Exploring the multifocal role of phytochemicals as immunomodulators. Biomed Pharmacother. 2021;133:110959. https:\/\/doi.org\/10.1016\/j.biopha.2020.110959.","journal-title":"Biomed Pharmacother"},{"key":"3020_CR115","doi-asserted-by":"publisher","DOI":"10.1016\/j.onano.2022.100118","volume":"9","author":"KR Chaudhary","year":"2023","unstructured":"Chaudhary KR, Kujur S, Singh K. Recent advances of nanotechnology in COVID 19: a critical review and future perspective. OpenNano. 2023;9:100118. https:\/\/doi.org\/10.1016\/j.onano.2022.100118.","journal-title":"OpenNano"},{"key":"3020_CR116","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2022.103553","volume":"74","author":"B Wilson","year":"2022","unstructured":"Wilson B, Geetha KM. Lipid nanoparticles in the development of mRNA vaccines for COVID-19. J Drug Deliv Sci Technol. 2022;74:103553. https:\/\/doi.org\/10.1016\/j.jddst.2022.103553.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3020_CR117","doi-asserted-by":"publisher","DOI":"10.1002\/wnan.1754","author":"J Wang","year":"2022","unstructured":"Wang J, Drelich AJ, Hopkins CM, Mecozzi S, Li L, Kwon G, et al. Gold nanoparticles in virus detection: recent advances and potential considerations for SARS-CoV\u20102 testing development. WIREs Nanomed Nanobiotechnol. 2022. https:\/\/doi.org\/10.1002\/wnan.1754.","journal-title":"WIREs Nanomed Nanobiotechnol"},{"issue":"9","key":"3020_CR118","doi-asserted-by":"publisher","DOI":"10.3390\/molecules30092004","volume":"30","author":"A Sati","year":"2025","unstructured":"Sati A, Ranade TN, Mali SN, Yasin HKA, Samdani N, Satpute NN, et al. Silver nanoparticles (AgNPs) as potential antiviral agents: synthesis, biophysical properties, safety, challenges and future directions update review. Molecules. 2025;30(9):2004. https:\/\/doi.org\/10.3390\/molecules30092004.","journal-title":"Molecules"},{"issue":"43","key":"3020_CR119","doi-asserted-by":"publisher","first-page":"26463","DOI":"10.1039\/d1ra04835j","volume":"11","author":"M Abd Elkodous","year":"2021","unstructured":"Abd Elkodous M, Olojede SO, Morsi M, El-Sayyad GS. Nanomaterial-based drug delivery systems as promising carriers for patients with COVID-19. RSC Adv. 2021;11(43):26463\u201380. https:\/\/doi.org\/10.1039\/d1ra04835j.","journal-title":"RSC Adv"},{"key":"3020_CR120","doi-asserted-by":"publisher","unstructured":"Sharma A, Kontodimas K, Bosmann M, Nanomedicine. A Diagnostic and Therapeutic Approach to COVID-19. Front. Med. 2021, 8. https:\/\/doi.org\/10.3389\/fmed.2021.648005","DOI":"10.3389\/fmed.2021.648005"},{"key":"3020_CR121","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtemb.2022.126977","volume":"72","author":"J Sarkar","year":"2022","unstructured":"Sarkar J, Das S, Aich S, Bhattacharyya P, Acharya K. Antiviral potential of nanoparticles for the treatment of coronavirus infections. J Trace Elem Med Biol. 2022;72:126977. https:\/\/doi.org\/10.1016\/j.jtemb.2022.126977.","journal-title":"J Trace Elem Med Biol"},{"key":"3020_CR122","doi-asserted-by":"publisher","unstructured":"Ranjan R. Omicron impact in india: analysis of the ongoing COVID-19 third wave based on global data. January 10, 2022. https:\/\/doi.org\/10.1101\/2022.01.09.22268969","DOI":"10.1101\/2022.01.09.22268969"},{"issue":"11","key":"3020_CR123","doi-asserted-by":"publisher","first-page":"833","DOI":"10.2217\/imt-2022-0064","volume":"14","author":"VP Chavda","year":"2022","unstructured":"Chavda VP, Hanuma Kumar Ghali EN, Yallapu MM, Apostolopoulos V. Therapeutics to tackle Omicron outbreak. Immunotherapy. 2022;14(11):833\u20138. https:\/\/doi.org\/10.2217\/imt-2022-0064.","journal-title":"Immunotherapy"},{"key":"3020_CR124","unstructured":"A monoclonal antibody stands out against omicron subvariants: a call to action for a wider access to bebtelovimab - The Lancet Infectious Diseases. https:\/\/www.thelancet.com\/journals\/laninf\/article\/PIIS1473-3099(22)00495-9\/fulltext (accessed 2025-07-04)."},{"issue":"16","key":"3020_CR125","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1056\/NEJMoa2119451","volume":"386","author":"N Andrews","year":"2022","unstructured":"Andrews N, Stowe J, Kirsebom F, Toffa S, Rickeard T, Gallagher E, et al. Covid-19 vaccine effectiveness against the Omicron (B.1.1.529) variant. N Engl J Med. 2022;386(16):1532\u201346. https:\/\/doi.org\/10.1056\/NEJMoa2119451.","journal-title":"N Engl J Med"},{"issue":"9","key":"3020_CR126","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1093\/jac\/dkae163","volume":"79","author":"YM Mesfin","year":"2024","unstructured":"Mesfin YM, Blais JE, Kibret KT, Tegegne TK, Cowling BJ, Wu P. Effectiveness of Nirmatrelvir\/Ritonavir and molnupiravir in non-hospitalized adults with COVID-19: systematic review and meta-analysis of observational studies. J Antimicrob Chemother. 2024;79(9):2119\u201331. https:\/\/doi.org\/10.1093\/jac\/dkae163.","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"3020_CR127","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.35077","volume":"6","author":"D-Y Lin","year":"2023","unstructured":"Lin D-Y, Abi Fadel F, Huang S, Milinovich AT, Sacha GL, Bartley P, et al. Nirmatrelvir or molnupiravir use and severe outcomes from Omicron infections. JAMA Netw Open. 2023;6(9):e2335077. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.35077.","journal-title":"JAMA Netw Open"},{"key":"3020_CR128","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2023.100755","volume":"35","author":"FCM Kirsebom","year":"2023","unstructured":"Kirsebom FCM, Harman K, Lunt RJ, Andrews N, Groves N, Abdul Aziz N, et al. Vaccine effectiveness against hospitalisation estimated using a test-negative case-control study design, and comparative odds of hospital admission and severe outcomes with COVID-19 sub-lineages BQ.1, CH.1.1 and XBB.1.5 in England. Lancet Reg Health. 2023;35:100755. https:\/\/doi.org\/10.1016\/j.lanepe.2023.100755.","journal-title":"Lancet Reg Health"},{"issue":"5","key":"3020_CR129","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2025.106461","volume":"90","author":"T Ward","year":"2025","unstructured":"Ward T, Paton RS, Overton CE, Mellor J, Aziz NA, Charlett A, et al. Understanding the effectiveness of the Comirnaty monovalent and bivalent vaccines during the winter coronavirus (COVID-19) infection study. J Infect. 2025;90(5):106461. https:\/\/doi.org\/10.1016\/j.jinf.2025.106461.","journal-title":"J Infect"},{"issue":"7","key":"3020_CR130","doi-asserted-by":"publisher","DOI":"10.1093\/jtm\/taab064","volume":"28","author":"K Sharun","year":"2021","unstructured":"Sharun K, Dhama K. India\u2019s role in COVID-19 vaccine diplomacy. J Travel Med. 2021;28(7):taab064. https:\/\/doi.org\/10.1093\/jtm\/taab064.","journal-title":"J Travel Med"},{"issue":"1159","key":"3020_CR131","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1136\/postgradmedj-2021-140654","volume":"98","author":"AI Francis","year":"2022","unstructured":"Francis AI, Ghany S, Gilkes T, Umakanthan S. Review of COVID-19 vaccine subtypes, efficacy and geographical distributions. Postgrad Med J. 2022;98(1159):389\u201394. https:\/\/doi.org\/10.1136\/postgradmedj-2021-140654.","journal-title":"Postgrad Med J"},{"issue":"3","key":"3020_CR132","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s12026-022-09265-0","volume":"70","author":"S Das","year":"2022","unstructured":"Das S, Kar SS, Samanta S, Banerjee J, Giri B, Dash SK. Immunogenic and reactogenic efficacy of covaxin and covishield: a comparative review. Immunol Res. 2022;70(3):289\u2013315. https:\/\/doi.org\/10.1007\/s12026-022-09265-0.","journal-title":"Immunol Res"},{"issue":"2","key":"3020_CR133","doi-asserted-by":"publisher","DOI":"10.34172\/ipp.2021.31","volume":"7","author":"N Ghiasi","year":"2021","unstructured":"Ghiasi N, Valizadeh R, Arabsorkhi M, Hoseyni TS, Esfandiari K, Sadighpour T, et al. Efficacy and side effects of Sputnik V, Sinopharm and AstraZeneca vaccines to stop COVID-19; a review and discussion. Immunopathol Persa. 2021;7(2):e31\u201331. https:\/\/doi.org\/10.34172\/ipp.2021.31.","journal-title":"Immunopathol Persa"},{"key":"3020_CR134","doi-asserted-by":"publisher","unstructured":"Iacobucci G. Covid-19: Single Vaccine Dose Is 33% Effective against Variant from India, Data Show. BMJ 2021, n1346. https:\/\/doi.org\/10.1136\/bmj.n1346","DOI":"10.1136\/bmj.n1346"},{"key":"3020_CR135","doi-asserted-by":"publisher","DOI":"10.1016\/j.nantod.2021.101142","volume":"38","author":"A Khurana","year":"2021","unstructured":"Khurana A, Allawadhi P, Khurana I, Allwadhi S, Weiskirchen R, Banothu AK, et al. Role of nanotechnology behind the success of mRNA vaccines for COVID-19. Nano Today. 2021;38:101142. https:\/\/doi.org\/10.1016\/j.nantod.2021.101142.","journal-title":"Nano Today"},{"key":"3020_CR136","unstructured":"Safety. and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1\/2 studies from Russia - The Lancet. https:\/\/www.thelancet.com\/article\/S0140-67362031866-3\/fulltext (accessed 2025-07-04)."},{"issue":"12","key":"3020_CR137","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10122146","volume":"10","author":"S Jaggaiahgari","year":"2022","unstructured":"Jaggaiahgari S, Munigela A, Mitnala S, Gujjarlapudi D, Simhadri V, D NR. Heterologous booster dose with CORBEVAX following primary vaccination with COVISHIELD enhances protection against SARS-CoV-2. Vaccines. 2022;10(12):2146. https:\/\/doi.org\/10.3390\/vaccines10122146.","journal-title":"Vaccines"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-03020-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-025-03020-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-03020-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T02:11:35Z","timestamp":1767060695000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12985-025-03020-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":137,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3020"],"URL":"https:\/\/doi.org\/10.1186\/s12985-025-03020-1","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,26]]},"assertion":[{"value":"10 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"404"}}